ValentinaNardiMD

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Assistant pathologist, Massachusetts General Hospital

Dr. Nardi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
101 Nicolls Rd
Boston, MA 11794
Phone+1 617-726-2967

Fax+1 617-726-7474

Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Molecular Genetic Pathology, 2012 - 2013
Massachusetts General HospitalFellowship, Hematopathology, 2010 - 2012
Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 2008 - 2012
Univ Genoa- Fac MedClass of 2000

PubMed

32 citations
GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas
Lauren L. Ritterhouse, Marina Vivero, Mari Mino-Kenudson, Lynette M. Sholl, A. John Iafrate
Modern Pathology. 2017-08-04
102 citations
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma
Lipika Goyal, Aparna Govindan, Rahul A. Sheth, Valentina Nardi, Lawrence S. Blaszkowsky
The Oncologist. 2015-09-01
26 citations
MarrowQuant Across Aging and Aplasia: A Digital Pathology Workflow for Quantification of Bone Marrow Compartments in Histological Sections.
Josefine Tratwal, David Bekri, Chiheb Boussema, Rita Sarkis, Nicolas Kunz
Frontiers in Endocrinology. 2020-09-24

Abstracts/Posters

Pregnancy Outcomes, Risk Factors, and Gestational Cell Count Trends in Pregnant Women with Essential Thrombocythemia and Polycythemia Vera
Valentina Nardi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Clinical, Immunophenotypic and Genomic Findings Â of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow P...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Newly Characterized Mutation May Define a Novel Leukemia Subtype in KidsFebruary 24th, 2022
Newly Characterized Mutation May Define Novel Pediatric AML SubtypeFebruary 17th, 2022
Case 37-2019: A 20-Month-Old Boy with Severe AnemiaNovember 28th, 2019